This report describes CDCâs recommendation that all people aged â¥65 years and people ages 6 monthsâ64 years with moderate or severe immunocompromise receive a second 2024â2025 COVID-19 vaccine dose 6 months after their last dose.
No takes yet. Share an insight, caveat, or question.
Roper et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: